Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000320967 | SCV000344940 | uncertain significance | not provided | 2016-08-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001458213 | SCV001662030 | likely benign | Episodic ataxia type 2; Developmental and epileptic encephalopathy, 42 | 2024-02-23 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003985320 | SCV004761674 | likely benign | CACNA1A-related disorder | 2021-11-05 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |